These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26406407)

  • 21. Androgen receptor gene polymorphism and breast cancer susceptibility in The Philippines.
    Liede A; Zhang W; De Leon Matsuda ML; Tan A; Narod SA
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):848-52. PubMed ID: 14504193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population.
    Giguère Y; Dewailly E; Brisson J; Ayotte P; Laflamme N; Demers A; Forest VI; Dodin S; Robert J; Rousseau F
    Cancer Res; 2001 Aug; 61(15):5869-74. PubMed ID: 11479228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
    Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
    Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgen receptor polymorphisms and testicular cancer risk.
    Grassetti D; Giannandrea F; Paoli D; Masciandaro P; Figura V; Carlini T; Rizzo F; Lombardo F; Lenzi A; Gandini L
    Andrology; 2015 Jan; 3(1):27-33. PubMed ID: 25180665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen receptor polymorphisms and endometrial cancer risk.
    McGrath M; Lee IM; Hankinson SE; Kraft P; Hunter DJ; Buring J; De Vivo I
    Int J Cancer; 2006 Mar; 118(5):1261-8. PubMed ID: 16161040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression.
    Nam RK; Elhaji Y; Krahn MD; Hakimi J; Ho M; Chu W; Sweet J; Trachtenberg J; Jewett MA; Narod SA
    J Urol; 2000 Aug; 164(2):567-72. PubMed ID: 10893645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen receptor status predicts response to chemotherapy, not risk of breast cancer in Indian women.
    Chintamani ; Kulshreshtha P; Chakraborty A; Singh L; Mishra AK; Bhatnagar D; Saxena S
    World J Surg Oncol; 2010 Aug; 8():64. PubMed ID: 20831839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures.
    Langdahl BL; Stenkjaer L; Carstens M; Tofteng CL; Eriksen EF
    Calcif Tissue Int; 2003 Sep; 73(3):237-43. PubMed ID: 14667136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer.
    Spurdle AB; Webb PM; Chen X; Martin NG; Giles GG; Hopper JL; Chenevix-Trench G
    Int J Cancer; 2000 Sep; 87(5):637-43. PubMed ID: 10925355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive association of the androgen receptor CAG repeat length polymorphism with the risk of prostate cancer.
    Paz-Y-Miño C; Robles P; Salazar C; Leone PE; García-Cárdenas JM; Naranjo M; López-Cortés A
    Mol Med Rep; 2016 Aug; 14(2):1791-8. PubMed ID: 27357524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Moderate HER2 expression as a prognostic factor in hormone receptor positive breast cancer.
    Eggemann H; Ignatov T; Burger E; Kantelhardt EJ; Fettke F; Thomssen C; Costa SD; Ignatov A
    Endocr Relat Cancer; 2015 Oct; 22(5):725-33. PubMed ID: 26187126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen receptor gene cytosine, adenine, and guanine trinucleotide repeats in patients with endometriosis.
    Lattuada D; Viganò P; Somigliana E; Odorizzi MP; Vignali M; Di Blasio AM
    J Soc Gynecol Investig; 2004 May; 11(4):237-40. PubMed ID: 15120698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat.
    Rebbeck TR; Kantoff PW; Krithivas K; Neuhausen S; Blackwood MA; Godwin AK; Daly MB; Narod SA; Garber JE; Lynch HT; Weber BL; Brown M
    Am J Hum Genet; 1999 May; 64(5):1371-7. PubMed ID: 10205268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen receptor expression shows distinctive significance in ER positive and negative breast cancers.
    Tsang JY; Ni YB; Chan SK; Shao MM; Law BK; Tan PH; Tse GM
    Ann Surg Oncol; 2014 Jul; 21(7):2218-28. PubMed ID: 24639191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Spurdle AB; Antoniou AC; Duffy DL; Pandeya N; Kelemen L; Chen X; Peock S; Cook MR; Smith PL; Purdie DM; Newman B; Dite GS; Apicella C; Southey MC; Giles GG; Hopper JL; Chenevix-Trench G; Easton DF;
    Breast Cancer Res; 2005; 7(2):R176-83. PubMed ID: 15743497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
    Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
    Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome.
    Ludwig AH; Murawska M; Panek G; Timorek A; Kupryjanczyk J
    Endocr Relat Cancer; 2009 Sep; 16(3):1005-16. PubMed ID: 19458022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microsatellite profile in hormonal receptor genes associated with breast cancer.
    Iobagiu C; Lambert C; Normand M; Genin C
    Breast Cancer Res Treat; 2006 Jan; 95(2):153-9. PubMed ID: 16317584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype.
    Sun X; Nichols HB; Tse CK; Bell MB; Robinson WR; Sherman ME; Olshan AF; Troester MA
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):60-7. PubMed ID: 26545404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.